Brumpost
  • COVID-19
  • Best Products
  • News
  • How Tos
  • The Bargainer
  • Reviews
  • Tireposts
  • @Work
  • 5G
No Result
View All Result
Brumpost
Home News Sci-Tech

EU criticizes the UK over hastened COVID-19 vaccine’s approval

EU claimed its own procedure on vaccine approval for the COVID-19 pandemic is meant to boost confidence in vaccines before being rolled out

Anna Xiaoling by Anna Xiaoling
5 months ago
in Sci-Tech
Reading Time: 4 mins read
A A
0
EU criticizes UK over hastened COVID-19 vaccine's approval

COVID-19 patient being treated by doctors (C)BBC.com

Share on FacebookShare on TwitterPin It

The United Nations has criticized the BUK government for its hastened approval of Pfizer and BionNTech’s COVID-19 vaccine on Wednesday. The EU stated that its own procedure was much more thorough. The UK is the first western country to endorse the use of a COVID19 vaccine eve though both China and Russia have also approved the use of vaccines to prevent the spread of the disease in their countries.

ADVERTISEMENT

Many has stated this to be based on political motivation since the UK left the EU under the administration of Prime Minster Boris Johnson who has earned criticism over his handling of the coronavirus outbreak in the country.

The emergency-use authorization was made under a really fast process which allowed the British drugs regulator to temporarily authorize the vaccine only 10 days after it started examining data from large-scale trials.

The European Medicines Agency (EMA) which is in charge of approving COVID-19 vaccines for the EU in a statement said its longer approval procedure was more appropriate as it was based on more evidence and also required more checks compared to emergency procedure which is the route taken by the British government.

According to the agency, it said it would decide by Dec. 29th on whether to provisionally authorize the vaccine from U.S. pharmaceutical company Pfizer and its German partner BioNTech.

A spokesman for the European Commission, the EU executive, said the EMA’s procedure was “the most effective regulatory mechanism to grant all EU citizens’ access to a safe and effective vaccine,” as it was based on more evidence.

Pfizer UK Country Manager Ben Osborn said, “We have provided complete data packages, the unblinded data, to both regulators. I think what you’re seeing is just the difference in the underlying process and timelines, as opposed to any difference in data submission.”

Meanwhile the head of Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) June Raine said “The way in which the MHRA has worked is equivalent to all international standards.

“Our progress has been totally dependent on the availability of data in our rolling review and our rigorous assessment and independent advice we have received,” she added.

As for the EMA on the other hand, the agency began rolling out preliminary data from Pfizer trials back in October 6th with an emergency procedure aimed at speeding up a possible approval which would usually take about 7 months rom the time of reception of full data.

The UK regulator launched its own rolling review on Oct. 30, and analysed less data than made available to the EMA.

“The idea is not to be first but to have a safe and effective vaccine,” Germany’s Health Minister Jens Spahn told a news conference. Jehs further added when asked about the emergency procedure used by Britain, he stated the EU countries had opted for a more thorough procedure in order to boost confidence in vaccines.

“If you evaluate only the partial data as they are doing they also take a minimum of risk,” the EMA’s former head Guido Rasi told an Italian radio.

“Personally I would have expected a robust review of all available data, which the British government has not done to be able to say that without Europe you come first,” he added.

EU lawmakers were even more explicit in their criticism of Britain’s move.

“I consider this decision to be problematic and recommend that EU Member States do not repeat the process in the same way,” said Peter Liese, an EU lawmaker who is a member of German Chancellor Angela Merkel’s party.

“A few weeks of thorough examination by the European Medicines Agency is better than a hasty emergency marketing authorisation of a vaccine,” said Liese, who represents the centre right grouping, the largest in the EU Parliament.

Under EU rules, the Pfizer vaccine must be authorised by the EMA, but EU countries can use an emergency procedure that allows them to distribute a vaccine at home for temporary use and not to forget that Britain is still subject to EU rules until it fully leaves at the end of the year.

“There is an obvious global race to get the vaccine on the market as fast as possible,” said Tiemo Wolken, an EU lawmaker from the socialist grouping, the second largest in the Parliament.

“However, I do believe that it is better to take the time and make sure that the quality, effectiveness and safety is guaranteed and matches our EU standards.”

For mroe information on the COVID-19 pandemic, please visit the CDC website for more information.

Source: Reuters
Tags: Coronavirus
HostGator Web Hosting
ADVERTISEMENT

Related Posts

Sci-Tech

Israeli researchers find Pfizer/BioNTech vaccines to be less effective on the South African strain of COVID-19

by Anna Xiaoling

A variant of the COVID-19 which was first discovered in the UK and South Africa are reportedly able to partially "breakthrough" the Pfizer/BioNTech vaccine based on a new study by...

Read more
Covid-19 vaccines side effects
Sci-Tech

These are the common and uncommon side effects of COVID-19 vaccines

by Anna Xiaoling

The World Health Organization maintained a good sentiment about a long-term side effects of the vaccines.

Read more
Industry News

Lawsuit against Amazon over lack of protection during pandemic moved to NY court

by Bree Tyller

The tussle between Amazon and its employees doesn't seems to be coming to an end soon

Read more
Sci-Tech

Did AstraZeneca relied on “outdated information” over its COVID-19 vaccine development

by Lisa Irène

Several European countries have halted the use of the vaccine due to severe side effects in recipients.

Read more
AstraZeneca successful COVID-19 vaccine
Sci-Tech

Two new cases of blood clot reported to Denmark authorities after taking AstraZeneca’s COVID-19 vaccine

by Anna Xiaoling

The country is among other European states that has temporarily halted the use of the vaccine while investigations are being carried out

Read more
Sci-Tech

Germany reportedly experiencing its third-wave of the COVID-19 pandemic

by Anna Xiaoling

A stricter lockdown measures might be put in place if number of confirmed cases rises

Read more
Leave Comment

TOP BARGAINS

The Bargainer

AllDoCube iPlay 40 UNNISOC T618 With 8GB of RAM and 128GB of Storage just got cheaper

The Bargainer

Enjoy a Massive discount for these BlitzWolf® over-ear Gaming Headphones

The Bargainer

This BlitzWolf® BW-FUN3 Wi-Fi Essential Oil Diffuser is offered with 40% off

The Bargainer

Save $70-$130 On Select Samsung Galaxy Tablets on Best Buy

The Bargainer

Save 45% on the Deerma DX700S 2-in-1 vacuum cleaner

BRUMPOST DAILY

Get caught up in minutes with our speedy summary of today’s tech happenings!
SUBSCRIBE

BEST HOLIDAY DEALS

BEST HOLIDAY DEALS

It’s holiday season and on Brumpost Bargainers, we actually get you the best values and amazing deals by scouring the entire web for the most affordable yet high quality products ever for you.

Learn more
  • About us
  • Advertise
  • Mobile
  • Write for us
  • FAQ
  • Cookie Policy
  • Contact us
  • Career
  • Terms of Use
Menu
  • About us
  • Advertise
  • Mobile
  • Write for us
  • FAQ
  • Cookie Policy
  • Contact us
  • Career
  • Terms of Use
© 2020 BRUMPOST MEDIA LLC
All Rights Reserved
FOLLOW US
AFFILIATE DISCLOSURE
Brumpost may get a commission from retail offers.
  • Login
  • Sign Up
No Result
View All Result
  • Tech News
    • Industry News
    • Gears & Gadgets
    • Sci-Tech
    • Culture
    • Enterprise
    • Rumors
  • Products Review
    • Smartphones
    • Smartwatches
    • Bluetooth Speakers
    • Headphones
    • PC & Computers
  • “How-to” Guide
    • Apps/Software
    • BP-Hack
    • Gadgets
    • Internet
  • Tirepost
    • Best Cars
    • Car Reviews
    • Latest News
  • @Work
  • The Bargainer
    • under $50
    • Under $100
    • Under $200
    • Under 300
    • under $400
    • Under $500
  • Videos
  • Pictures
  • COVID-19 Monitor

©Copyright 2018 Brumpost Media, Inc.

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

*By registering into our website, you agree to the Terms & Conditions and Privacy Policy.
All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
DON’T MISS OUT AGAIN!
GET THE LATEST UPDATES IN YOUR INBOX EVERYDAY
FREE SIGN UP
By signing up, you agree to BRUMPOST Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Learn how to grow every aspect of your
GET THE BEST SMALL BUSINESS RESOURCES & TIPS DAILY
FREE SIGN UP
By signing up, you agree to BRUMPOST Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
GO
Sign-up for exclusive content. Be the first to hear about Brumpost Tech news.
Subscribe
close-image

astronaut astronomy cosmonaut galaxy RECENT VIDEOS play_circle_outline Watch NASA's Next Spacewalk on Saturday March 13th Apple iPhone 12 Pro Max leaked in a new video RECENT VIDEOS play_circle_outline Alleged iPhone 12 Pro Max leaked video showed some interesting features Zack Snyder's Justice League trailer RECENT VIDEOS play_circle_outline This is the first trailer for the Zack Snyder's Justice League Galaxy Fold 2 RECENT VIDEOS play_circle_outline Galaxy Fold 2 appears in a teaser hinting possible release things to consider before buying a smartphone RECENT VIDEOS play_circle_outline Top 8 things to consider before buying a smartphone in 2020
close-link

WE'VE GOT BUNCH OF COOKIES HERE!

Brumpost uses cookies to enhance your experience and by continuing to use the website, you are giving consent to those cookies being used. To learn more, click below
COOKIE POLICY
close-link
Click Me

Get caught up in minutes with our speedy summary of today’s tech happenings!
SUBSCRIBE